BioSpace News Archive

Policy

Medtronic Forks Over $12M to Settle Infuse False Marketing Claims

The Mass. Attorney General said the deal will resolve an investigation by her office and those in four other states related to Medtronic’s promotion of Infuse.

December 14, 2017
·
1 min read
FDA

Karolinska Development’s Portfolio Company Promimic Receives FDA Approval for HAnano Surface for Use on Dental Implants

The approval of HAnano Surface in the United States has been executed in accordance with the new 510(k) legislation for medical devices.

December 14, 2017
·
1 min read
Genetown

AbbVie, Pfizer Jump in on Newly-Launched Jnana Therapeutics’ $50M Funding Round

Seed funders Polaris Partners and Avalon Ventures were joined in the round by Versant Ventures, AbbVie Ventures and Pfizer R&D Innovate.

December 14, 2017
·
2 min read
·
Mark Terry
Business

These 2 Startups are Amgen’s 2017 Golden Ticket Winners

Amgen tapped two companies to receive its coveted 2017 Golden Ticket at LabCentral.

December 14, 2017
·
3 min read
·
Alex Keown
Drug Development

Merck’s Ace Keytruda Flunks Key Phase III Stomach Cancer Study

Merck’s Keytruda came up short in a pivotal Phase III trial as a second-line treatment for patients with advanced gastricadenocarcinoma or GEJ adenocarcinoma.

December 14, 2017
·
2 min read
·
Alex Keown
Business

Asklepios BioPharma Launches New Biotech Actus Therapeutics

Asklepios BioPharma is forming a new biotech portfolio company, Actus Therapeutics.

December 14, 2017
·
2 min read
·
Mark Terry